Arthur David J. 4/A
4/A · Salarius Pharmaceuticals, Inc. · Filed Nov 8, 2022
Insider Transaction Report
Form 4/AAmended
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-11-03$1.73/sh+10,000$17,340→ 21,026 total
Holdings
- 564(indirect: By son)
Common Stock
- 552(indirect: By daughter)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)